Volume : 09, Issue : 06, June – 2022

Title:

49.NEUROLOGICAL DISORDERS AND DISEASES: PREVALANCE AND INCIDENCE IN TERTIARY CARE HOSPITAL

Authors :

N. Manichandana*, V. Srilatha, B.Vijatha, R.Tulsi, Dr.Amatul Ali Sameera

Abstract :

Aims and objectives: The aim is to explore concerning prevalence and incidence of neurological diseases and disorders with in a tertiary care hospital. Methods: A prospective, observational study was conducted out throughout the neurology department of Aware Gleneagles Global Hospitals, Hyderabad. A maximum of 161 cases were been eventually diagnosed to neurological disorders in the in-patient Department, study was carried out for a period of 6 months categorized based on the inclusion and exclusion criteria. On the side of the study, data was obtained from in-patient case records, and patients were assessed accordingly. Results: A total of 161 patients were chosen, with males comprising 98 (61%) and females accounting 63 (39%). Most people affected belonged to the age group of 51- 60 years. 78 % of the subjects had coexisting diseases. Subjects with neurological disorders that had been diagnosed were stroke 70, migraine 6, vertigo 4, meningitis 2, meningoencephalitis 3, vestibular neuronitis 5, seizures 34, neuropathies 7, Guillian Barre syndrome 16, psychiatric disorders 6, Parkinson’s disease 9, spinal injury 16, brain tumors 2, traumatic brain injury 12, sciatica 2, and in Alzheimer’s disease, bell’s palsy, trigeminal neuralgia, headache, intracranial hypertension, Sjogren’s syndrome, myasthenia gravis are of 1 in each. Guillian Barre syndrome was 95 % more prone in autoimmune disorders, with GBS with autonomic neuropathy 13 %, GBS with Hepatopathy 10%, and GBS+AIDP, CIDP, and Diabetic neuropathy 1 in each. Subjects with traumatic brain injury had their GCS scores properly assessed, and thus 25 % had GCS 3-8, 42 % had GCS 9-12, and 33 % had GCS 13-15. Conclusion: The prevalence and incidence of neurological disease and disorders were studied first at demographics of the patients; it was observed that males are more prone to neurological ailments, while their age range is between 13 and 85 years.
Key words: Stroke, seizures, migraine, guillian barre syndrome, myasthenia gravis.

Cite This Article:

Please cite this article in press N.Manichandana et al, Neurological Disorders And Diseases: Prevalence And Incidence In Tertiary Care Hospital., Indo Am. J. P. Sci, 2022; 09(6).,

Number of Downloads : 10

References:

1. ACGME (1 July 2016). “ACGME Program Requirements for Graduate Medical Education in Neurology” (PDF). www.acgme.org. Archived from the original (PDF) on 13 January 2017. Retrieved 10 January 2017.
2. Nervous System Diseases – Neurologic Diseases”. MedlinePlus. Retrieved 2022-02-02.
3. World Health Organisation. What are neurological disorders? Available from: https://www.who.int/news-room/q-a-detail/what-are-neurological-disorders# (accessed 22 September, 2021).
4. “What Is a Stroke?”. www.nhlbi.nih.gov/. March 26, 2014. Archived from the original on 18 February 2015. Retrieved 26 February 2015.
5. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014; 55 (4): p.475-482. doi: 10.1111/epi.12550.
6. Shorvon SD, Andermann F, Guerrini R. (ed.). 2011. The causes of epilepsy. Cambridge University Press, Cambridge.
7. Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. Handb Clin Neurol. 2012;107:113–33.
8. Goodman C, Fuller K. Pathology: Implications for the Physical Therapist. 3rd ed. St. Louis, Missouri: Saunders Elsevier, 2009.
9. Sáez-Llorens X, McCracken GH (June 2003). “Bacterial meningitis in children”. Lancet. 361 (9375): 2139–48. doi:10.1016/S0140-6736(03)13693- 8. PMID 12826449. S2CID 6226323.
10. “Dementia Fact sheet”. World Health Organization. September 2020.
11. Leray E, Moreau T, Fromont A, Edan G (January 2016). “Epidemiology of multiple sclerosis”. Revue Neurologique. 172 (1): 3–13. doi:10.1016/j.neurol.2015.10.006. PMID 26718593.
12. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517.
13. Korn, T. 2008. Pathophysiology of multiple sclerosis. Journal of Neurology. 255: (6) 2-6
14. Berer K, Krishnamoorthy G (November 2014). “Microbial view of central nervous system autoimmunity”. FEBS Letters. 588 (22): 4207–13. doi:10.1016/j.febslet.2014.04.007. PMID 24746689. S2CID 2772656.
15. Faedda, N., Cerutti, R., Verdecchia, P., Migliorini, D., Arruda, M., and Guidetti, V. (2016).Behavioral Management of Headache in Children and Adolescents. J. Headache Pain 17 (1), 80. doi:10.1186/s10194-016-0671-4
16. Headache disorders”. The World Health Organization. 8 April 2016. Retrieved 2021-12- 14 199. 17.”headache | Britannica”. www.britannica.com. Retrieved 2022-04-29.
18. Spinal cord tumors. Arnautović, Kenan I.,, Gokaslan, Ziya L. Cham, Switzerland. 2018. ISBN 978-3-319-99438-3. OCLC 1084270205.